Dr. Ali El-Ghamrawy, Chairman of the Egyptian Drug Authority, held a meeting with Dr. Nazmi Namis Massoud, Chairman of the Board of Sunny Pharmaceutical, as part of efforts to support export activities and strengthen the presence of Egyptian pharmaceutical products in international markets.
The meeting discussed mechanisms for supporting and developing the company’s export portfolio, as well as reviewing future plans to expand into foreign markets under the umbrella of the Authority. Ways to cooperation in the field of export were also explored, with a particular focus on exporting pharmaceutical products to African markets, in line with the Authority’s strategy to strengthen Egypt’s position as a regional hub for pharmaceutical exports.
Dr. El-Ghamrawy affirmed that the Authority is working to enhance the global presence of Egyptian medicine, stressing the importance of cooperation with Egyptian companies to expand export activities and achieve regional leadership in the pharmaceutical manufacturing and trade sector. He further explained that developing the export file is not limited to supporting companies only, but also includes strengthening international confidence in Egyptian products in accordance with the highest standards of quality and safety. This contributes to enhancing national pharmaceutical security and consolidating Egypt’s position as a leading regional hub in the pharmaceutical sector.
For his part, Dr. Nazmi Massoud expressed his appreciation for the pioneering role played by the Egyptian Drug Authority in supporting the national pharmaceutical industry and promoting exports, affirming that the Authority represents a strategic partner in enabling Egyptian products to reach regional and international markets. This reflects the quality of Egyptian products and enhances the confidence of external markets in the capabilities of the national pharmaceutical sector and the pharmaceutical system in Egypt.
This comes within the framework of the Egyptian Drug Authority’s strategic direction towards developing effective partnerships with local and international pharmaceutical companies, contributing to the achievement of national pharmaceutical security, meeting patients’ needs, and strengthening Egypt’s position as a regional center for pharmaceutical manufacturing and trade.